A small and thin slice of endometrial tissue, the innermost lining of the uterus, is obtained for disease identification and testing during an endometrial biopsy. Endometrial biopsy cannulae are used to diagnose infertility, amenorrhea, uterine malignancy, abnormal uterine bleeding, and endometrial infection in the clinic. Endometrial biopsy cannulae come in a variety of sizes. They are effective and affordable small medical device used for regular diagnostic practice.
Get Sample Report with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-sample/1937
Because of its accuracy, disease identification by biopsy is gaining traction, which is projected to drive the endometrial biopsy cannulae market growth over the forecast period. According to the National Cancer Institute, endometrial cancer is detected at an early stage in 85 percent of cases utilising endometrial sample or biopsy. Moreover, increasing incidences of uterine related diseases are driving growth of the endometrial biopsy cannulae market.
Endometrial Biopsy Cannulae Market Dynamics
The key factor driving demand for endometrial biopsy cannulae is the rising prevalence of uterine cancer, which is boosting the endometrial biopsy cannulae market size. According to the National Cancer Institute’s Surveillance, Epidemiology, and End Results Program, an estimated 63,230 new cancer cases would be recorded in the United States in 2018, accounting for 26.0 percent of all cancer cases per 100,000 women. Furthermore, according to the same source, an estimated 2.9 percent of women will develop uterine cancer during their lifetime. As a result, people who are at high risk of getting cancer are more likely to be diagnosed with cancer, which drives up demand for endometrial biopsy cannulae According to the American Cancer Society’s (ACS) publication Cancer Facts & Figures 2018, around 92 percent of uterine cancer is found in the endometrial lining, and obesity raises the chance of uterine cancer development proportionately. Biopsy is also used to detect infertility, and the rising prevalence of infertility-related diseases is likely to drive the endometrial biopsy cannulae market over the forecast period. For example, according to Maternal Health Task Force (MHTF), a project of the Women and Health Initiative at the Harvard T.H. Chan School of Public Health, 2017, nearly 50 million couples experience infertility, worldwide.
Purchase This Premium Report Here To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/1937
Abnormal uterine bleeding is another serious clinical issue that necessitates an endometrial biopsy. Heavy monthly bleeding affects 14-25 percent of women of reproductive age, according to Best Practice & Research. Clinical Obstetrics & Gynecology, 2016. Furthermore, it claims that 800,000 women seek medical help each year for irregular uterine bleeding. Increased efforts to raise public awareness about the necessity of early detection of diseases like cancer in order to prevent morbidity are predicted to enhance the endometrial biopsy cannulae market.. For example, governments and non-governmental organizations organize programs to spread awareness about early detection of cancer and its importance and also recommend for the periodic check-ups for cancer. Furthermore, consultation with respect to infertility are increasing at fast pace, owing to increasing awareness, which in turn is propelling the market growth.
Endometritis, or uterine infection, is another common illness that necessitates medical attention in low-income countries. Chronic endometritis, for example, affects about 10% of the population, according to Clinical and Experimental Reproductive Medicine, 2016.Complications related with the use of endometrial biopsy cannulae, such as uterine or cervical damage, pelvic infection, vagal response, inadequate evacuation, or acute hematometra, are projected to stymie market expansion. Alternative biopsy methods, such as imagining techniques or vaginal fine-needle aspiration, are also projected to limit market expansion.
Endometrial Biopsy Cannulae Market – Regional Analysis
Coherent Market Insights divides the global endometrial biopsy cannulae market into five regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The endometrial biopsy cannulae market in North America is the most competitive in the area. . The rising frequency of uterine cancer is one of the factors contributing to North America’s market dominance. For example, between 2005 and 2014, the incidence of uterine cancer in white women increased by 1% every year, according to the National Cancer Institute. However, Asia Pacific and Africa provides good opportunity for the market players to expand their product range to fulfil the unmet medical needs in low income economies.
Major players in the global endometrial biopsy cannulae market include Medline Industries, Inc., CooperSurgical, Inc., MedGyn Products, Inc., Gyneas, Andemed, Nuode, Saipu, Micromed, and Panpac Medical & RI.MOS.
Endometrial Biopsy Cannulae Market Taxonomy
Based on product type:
Rigid Endometrial Biopsy Cannulae
Flexible Endometrial Biopsy Cannulae
Based on end user:
Based on region:
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/1937
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027